Novanta Inc, together with its subsidiaries, designs, manufactures, markets, and sells photonics, vision, and precision motion components and sub-systems to original equipment manufacturers in the medical and industrial markets worldwide. The company's Photonics segment offers photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products for photonics-based applications, such as industrial material processing, metrology, medical and life science imaging, DNA sequencing, and medical laser procedures.
Read More…
Industry, Sector and Symbol
Industry Miscellaneous electrical machinery, equipment, & supplies
Sub-IndustryN/A
SectorComputer and Technology
Phone781-266-5700
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$614.34 million
Profitability
Miscellaneous
Employees2,133
Next Earnings Date2/26/2020 (Confirmed)
OptionableOptionable
Novanta (NASDAQ:NOVT) Frequently Asked Questions
What is Novanta's stock symbol?
Novanta trades on the NASDAQ under the ticker symbol "NOVT."
How were Novanta's earnings last quarter?
Novanta Inc (NASDAQ:NOVT) issued its quarterly earnings results on Tuesday, November, 5th. The technology company reported $0.53 earnings per share for the quarter, beating analysts' consensus estimates of $0.52 by $0.01. The technology company earned $154.10 million during the quarter, compared to analyst estimates of $155.04 million. Novanta had a net margin of 6.94% and a return on equity of 20.01%. Novanta's revenue for the quarter was down 4.2% compared to the same quarter last year. During the same quarter last year, the business posted $0.61 earnings per share. View Novanta's Earnings History.
When is Novanta's next earnings date?
What price target have analysts set for NOVT?
1 analysts have issued 12 month price objectives for Novanta's stock. Their forecasts range from $81.00 to $81.00. On average, they expect Novanta's stock price to reach $81.00 in the next year. This suggests that the stock has a possible downside of 5.1%. View Analyst Price Targets for Novanta.
What is the consensus analysts' recommendation for Novanta?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Novanta in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Novanta.
Has Novanta been receiving favorable news coverage?
Media coverage about NOVT stock has trended neutral recently, InfoTrie reports. InfoTrie identifies positive and negative news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Novanta earned a news impact score of 0.2 on InfoTrie's scale. They also assigned media stories about the technology company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for Novanta.
Are investors shorting Novanta?
Novanta saw a decrease in short interest in the month of January. As of January 31st, there was short interest totalling 704,800 shares, a decrease of 6.0% from the January 15th total of 749,800 shares. Based on an average daily volume of 139,700 shares, the days-to-cover ratio is currently 5.0 days. Currently, 2.1% of the company's stock are sold short. View Novanta's Current Options Chain.
Who are some of Novanta's key competitors?
Some companies that are related to Novanta include CAE (CAE), Energizer (ENR), Integer (ITGR), Spectrum Brands (SPB), Atkore International Group (ATKR), FuelCell Energy (FCEL), Ultralife (ULBI), Arotech (ARTX), Flux Power (FLUX), Sono-Tek (SOTK), Polar Power (POLA), CBAK Energy Technology (CBAT), Security Devices International (SDEV), Evans & Sutherland Computer (ESCC) and mPhase Technologies (XDSL).
What other stocks do shareholders of Novanta own?
Who are Novanta's key executives?
Novanta's management team includes the folowing people:
- Mr. Matthijs Glastra, CEO & Director (Age 50)
- Mr. Robert J. Buckley, Chief Financial Officer (Age 45)
- Mr. Brian S. Young, Chief HR Officer (Age 50)
- Mr. Peter L. Chang, VP, Corp. Controller & Chief Accounting Officer (Age 54)
- Mr. Heinrich Dreyer, Group Pres of Minimally Invasive Surgery
Who are Novanta's major shareholders?
Novanta's stock is owned by a number of of retail and institutional investors. Top institutional investors include Alliancebernstein L.P. (5.30%), William Blair Investment Management LLC (2.90%), Artisan Partners Limited Partnership (2.83%), Conestoga Capital Advisors LLC (2.73%), Janus Henderson Group PLC (2.06%) and Paradice Investment Management LLC (2.00%). Company insiders that own Novanta stock include Matthijs Glastra, Peter L Chang, Robert Buckley and Stephen W Bershad. View Institutional Ownership Trends for Novanta.
Which institutional investors are selling Novanta stock?
NOVT stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Goldman Sachs Group Inc., Fred Alger Management LLC, AXA, Westwood Holdings Group Inc., Alliancebernstein L.P., PNC Financial Services Group Inc. and Stifel Financial Corp. Company insiders that have sold Novanta company stock in the last year include Matthijs Glastra, Peter L Chang, Robert Buckley and Stephen W Bershad. View Insider Buying and Selling for Novanta.
Which institutional investors are buying Novanta stock?
NOVT stock was bought by a variety of institutional investors in the last quarter, including Eventide Asset Management LLC, Conestoga Capital Advisors LLC, William Blair Investment Management LLC, Artisan Partners Limited Partnership, GW&K Investment Management LLC, Sei Investments Co., Geode Capital Management LLC and Janus Henderson Group PLC. View Insider Buying and Selling for Novanta.
How do I buy shares of Novanta?
Shares of NOVT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Novanta's stock price today?
One share of NOVT stock can currently be purchased for approximately $85.36.
How big of a company is Novanta?
Novanta has a market capitalization of $2.99 billion and generates $614.34 million in revenue each year. The technology company earns $49.11 million in net income (profit) each year or $2.16 on an earnings per share basis. Novanta employs 2,133 workers across the globe.View Additional Information About Novanta.
What is Novanta's official website?
How can I contact Novanta?
Novanta's mailing address is 125 Middlesex Turnpike, Bedford MA, 01730. The technology company can be reached via phone at 781-266-5700 or via email at [email protected]
MarketBeat Community Rating for Novanta (NASDAQ NOVT)
MarketBeat's community ratings are surveys of what our community members think about Novanta and other stocks. Vote "Outperform" if you believe NOVT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NOVT will underperform the S&P 500 over the long term. You may vote once every thirty days.
